...
首页> 外文期刊>BMC Infectious Diseases >Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)
【24h】

Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)

机译:居住在边界地区普利亚的儿童和青少年针对脊髓灰质炎病毒的免疫状况的血清学调查(意大利南部)

获取原文

摘要

Background In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by routine immunization using Oral Polio Vaccine (OPV). On 21 June 2002 the WHO European Region was declared polio-free. In 2008 poliomyelitis is still endemic in 4 countries (Nigeria, India, Pakistan, and Afghanistan), where 1201 new cases were registered in 2007; 107 sporadic cases were also notified in countries where poliovirus is not endemic. The aim of this work was to verify the level of antipoliomyelitis immunity status in children and adolescents in the Apulia region (south of Italy), which may be considered a border region due to its position. Methods 704 blood specimens from a convenience sample were collected in six laboratories. The age of subjects enrolled was 0–15 years. The immunity against poliomyelitis was evaluated by neutralizing antibody titration in tissue culture microplates. Results Seropositivity (neutralising antibodies titre ≥ 8) for polioviruses 1, 2 and 3 was detected in 100%, 99.8% and 99.4% of collected sera. Antibody titres were not lower in subjects who received either four doses of inactivated polio vaccine (IPV) or a sequential schedule consisting of two doses of IPV and two of oral polio vaccine than in subjects who received four doses of OPV. Conclusion These results confirmed current data of vaccine coverage for poliomyelitis: during the last ten years in Apulia, the coverage in 24 months old children was more than 90%. The high level of immunization found confirms the effectiveness both of the sequential schedule IPV-OPV and of the schedule all-IPV. Apulia region has to face daily arrivals of refugees and remains subject to the risk of the importation of poliovirus from endemic areas. Surveys aimed at determining anti-polio immunity in subpopulations as well as in the general population should be carried out.
机译:背景技术1988年,世界卫生大会通过了使用口服脊髓灰质炎疫苗(OPV)进行常规免疫接种来根除脊髓灰质炎的目标。 2002年6月21日,世界卫生组织欧洲区域宣布无小儿麻痹症。 2008年,脊髓灰质炎在4个国家(尼日利亚,印度,巴基斯坦和阿富汗)仍然很流行,2007年新登记了1201例新病例。在脊髓灰质炎不是地方流行的国家,也报告了107例散发病例。这项工作的目的是验证普利亚地区(意大利南部)儿童和青少年的抗脊髓灰质炎免疫状态水平,该地区因其位置可能被视为边境地区。方法在六个实验室中,从便利样本中采集704个血液样本。受试者的年龄为0-15岁。通过在组织培养微孔板中中和抗体滴定来评估针对脊髓灰质炎的免疫力。结果在收集到的血清中分别有100%,99.8%和99.4%检出了脊髓灰质炎病毒1、2和3的血清阳性(中和抗体滴度≥8)。与接受四剂OPV的受试者相比,接受四剂灭活的脊髓灰质炎疫苗(IPV)或由两剂IPV和两种口服脊髓灰质炎疫苗组成的顺序给药方案的受试者的抗体滴度不低。结论这些结果证实了脊髓灰质炎疫苗覆盖率的最新数据:在最近十年的普利亚,24个月大儿童的覆盖率超过90%。发现的高水平免疫证实了顺序IPV-OPV计划和全IPV计划的有效性。普利亚地区必须面对难民的每日到来,仍然面临着从流行地区进口脊髓灰质炎病毒的风险。应当进行旨在确定亚人群以及普通人群中抗策略性免疫力的调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号